Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Polivy
Pharma
ASH: Lilly defends survival data blemish in novel BTK trial win
The overall survival analysis created a bit of a problem for Lilly as the hazard ratio edged above 1 in favor of control.
Angus Liu
Dec 9, 2024 5:45pm
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
Dec 4, 2024 12:52pm
Vabysmo soars as Roche grows through COVID sales declines
Feb 1, 2024 11:36am
ASH: Roche offers glimpse at Columvi-Polivy combo in DLBCL
Dec 11, 2023 7:00am
With Polivy beat, Roche fleshes out blood cancer ambitions
Oct 19, 2023 11:28am
Roche's star eye drug Vabysmo crosses blockbuster threshold
Jul 27, 2023 11:04am
